U
Build Your Knowledge
Disease pathwayKidney / Upper Tract

Benign Renal Tumors

Not every solid renal lesion is cancer — angiomyolipoma and oncocytoma are benign, but the trap is that fat-poor AML and oncocytoma can be indistinguishable from RCC on imaging.

Fat
= AML
+
No fat
RCC until proven otherwise
+
AML risk
bleeding
Orientation

The big picture

The common benign lesions are simple cysts, angiomyolipoma (AML — fat-containing) and oncocytoma. Macroscopic fat on CT effectively diagnoses AML; oncocytoma has no reliable imaging signature and often needs biopsy or excision to distinguish from RCC.

Golden rule

Macroscopic fat means AML; a fat-poor solid enhancing mass is RCC until proven otherwise — and large AMLs need treatment for bleeding risk.

Presentation

Symptom sorter

Commonest benign lesion.

Thin-walled, non-enhancingBosniak I–IINo follow-up needed
Work-up

Diagnostic algorithm

Each step answers one question. Tap to expand.

Management

Treatment ladder

Confirm benignity where possible; treat AML by size and bleeding risk and treat indeterminate solid masses as RCC.

1
Characterise (fat?)
2
AML small → surveil
3
AML large/bleeding → embolise (or surgery)
4
Indeterminate solid → biopsy or treat as RCC
Procedures

Procedure chooser

Surgical / procedural options
  • Nephron-sparing surgery for large symptomatic AML or indeterminate masses
Safety

Complications

Disease complications
  • Retroperitoneal haemorrhage from large AML
  • Missed RCC masquerading as benign
Treatment complications
  • Embolisation post-infarction syndrome
  • Surgical loss of nephrons
How to prevent
  • Treat large AMLs proactively
  • Biopsy/treat indeterminate masses as RCC
How to manage
  • Embolise bleeding AML
  • Excise indeterminate lesions
Safety

Red flags

Acute flank pain with a known large AML (bleeding)
Solid enhancing mass without fat (treat as RCC)
Reference

Summary tables

Benign renal tumours

LesionImaging clueManagement
Simple cystThin, non-enhancingReassure
AMLMacroscopic fatSurveil; embolise/operate if large/bleeding
OncocytomaCentral scar (unreliable)Often biopsy/excise (RCC mimic)
Fat-poor AMLNo fat, mimics RCCBiopsy or treat as RCC
Recall

Memory hooks

Macroscopic fat = AML.

No fat + enhancing = RCC until proven otherwise.

Big AML = bleeding risk → treat.

Oncocytoma: benign but a mimic.

Exam

Board traps

Fat-poor AML indistinguishable from RCC — do not assume benign.

Large AML with acute flank pain — Wunderlich (retroperitoneal) haemorrhage.

Multiple bilateral AMLs — think tuberous sclerosis.

Apply

Clinical cases

Case 1

A 45-year-old woman has a 6 cm renal lesion with abundant macroscopic fat on CT and intermittent flank pain.

What is the lesion and the main management concern?

Test yourself

Quiz

Back to all modules